EUVIMEDEUVIMED entdecken
Open Access

Genetic mutation of Frem3 does not causeFraser syndrome in mice

Daiji Kiyozumi, Masashi Mori, Mayo Kodani, Masahito Ikawa

Experimental Animals · 2020 · 69 (1) · 104-109

DOI: 10.1538/expanim.19-0088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Animals, 2020. Verfasst von Daiji Kiyozumi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Microbial Diseases, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan. Hauptthemen laut MEDLINE: Mutation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

QBRICK, FRAS1, and FREM2 compose a family of extracellular matrix proteins characterized by twelve consecutive CSPG repeats and single or multiple Calx-β motifs. Dysfunction of these proteins have been associated with Fraser syndrome, which is characterized by malformation of skin, eyes, digits, and kidneys. FREM3 is another member of the 12-CSPG protein family. However, it remains unknown whether genetic dysfunction of FREM3 also causes Fraser syndrome or another developmental disorder. Here we investigated a Frem3 mutant mouse line generated by CRISPR/Cas9-mediated genome editing. The FREM3 mutant homozygotes were born at the expected Mendelian ratio and did not possess any defects characteristic of Fraser syndrome. These results indicate that the dysfunction of FREM3 is not associated with Fraser syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutationAnimalsExtracellular Matrix ProteinsFraser SyndromeMice

Stichwörter der Autor:innen

Bifid Nose Renal Agenesis and Anorectal malformations (BNAR)CRISPR/Cas9Fraser syndromeFrem3Manitoba-oculo-tricho-anal syndrome (MOTA).

Substanzen

Extracellular Matrix ProteinsFrem3 protein, mouse

Autor:innen und Institutionen

  • Research Institute for Microbial Diseases, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Immunology Frontier Research Center, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Graduate School of Pharmaceutical Sciences, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • Graduate School of Medicine, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
  • The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.

Zitieren

APA

Kiyozumi, D., Mori, M., Kodani, M., & Ikawa, M. (2020). Genetic mutation of Frem3 does not causeFraser syndrome in mice. Experimental Animals, 69(1), 104-109. https://doi.org/10.1538/expanim.19-0088

Vancouver

Kiyozumi D, Mori M, Kodani M, Ikawa M. Genetic mutation of Frem3 does not causeFraser syndrome in mice. Experimental Animals. 2020;69(1):104-109. doi:10.1538/expanim.19-0088

BibTeX
@article{Kiyozumi2020,
  author = {Kiyozumi, Daiji and Mori, Masashi and Kodani, Mayo and Ikawa, Masahito},
  title = {Genetic mutation of Frem3 does not causeFraser syndrome in mice},
  journal = {Experimental Animals},
  year = {2020},
  volume = {69},
  number = {1},
  pages = {104--109},
  doi = {10.1538/expanim.19-0088}
}
Kostenlos starten →